Abiopharma

🔍 Lundgren Tamara L. (Director)

Company: RYDER SYSTEM INC (R)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 720 shares of common stock (Direct)
  Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 32,076.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 304 shares of common stock (Direct)
  Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 32,672.00 | transaction_form_type: 4 | Footnotes: F2, F3

Footnotes:

• F1: Annual grant of $180,000 of restricted stock units pursuant to the Company's Amended and Restated 2019 Equity and Incentive Compensation Plan based on $249.99 per share, which was the last reported sale price of the Company's common stock on May 1, 2026.
• F2: Grant of restricted stock units pursuant to the dividend reinvestment feature of the Issuer's Amended and Restated 2019 Equity and Incentive Compensation Plan.
• F3: Includes 292 shares of common stock acquired by the reporting person under the Company's dividend reinvestment plan since the date of the reporting person's last Section 16 filing.